Zobrazeno 1 - 10
of 101
pro vyhledávání: '"E. I. Burtseva"'
Autor:
E. I. Burtseva, L. V. Kolobukhina, O. L. Voronina, A. V. Ignatjeva, E. A. Mukasheva, A. D. Panova, E. L. Feodoritova, K. G. Krasnoslodotsev, S. V. Trushakova, L. N. Merkulova, I. N. Khlopova, N. V. Breslav, N. N. Ryzhova, M. S. Kunda, E. I. Aksenova, R. V. Vartanyan, L. B. Kisteneva, O. A. Burgasova, A. G. Rosatkevich, I. S. Kruzhkova, M. V. Bazarova, S. V. Smetanina, N. A. Tsvetkova, Yu. S. Levochkina, M. V. Kozlova, D. O. Korostin, E. I. Botsmanov
Publikováno v:
Эпидемиология и вакцинопрофилактика, Vol 21, Iss 4, Pp 16-26 (2022)
Relevance. The long-term leadership of ARVI pathogens determines their significance in the damage caused to both health and the economy of the country. Aim. To identify the features of the structure of ARVI during the emergence and widespread spread
Externí odkaz:
https://doaj.org/article/2ad3ac4edaf3443f95f43f0c880cc93c
Autor:
T. A. Semenenko, V. G. Akimkin, E. I. Burtseva, A. V. Nozdracheva, E. G. Simonova, A. V. Tutelyan, S. V. Ugleva, S. N. Kuzin
Publikováno v:
Эпидемиология и вакцинопрофилактика, Vol 21, Iss 4, Pp 4-15 (2022)
Annualy, SARS occupy a leading position in terms of morbidity and the magnitude of the economic damage caused both in the world and in the Russian Federation. Currently, the most widespread pandemics are caused by the influenza A (H1N1) pdm09 virus a
Externí odkaz:
https://doaj.org/article/e6b23fe9a03e48ae9604d612e46f4192
Autor:
A. A. Girina, A. L. Zaplatnikov, E. I. Burtseva, V. I. Svintsitskaya, I. D. Maykova, N. F. Dubovets, N. V. Koroid, I. V. Lepiseva, A. Е. Voskanyan, D. N. Tkacheva, A. D. Panova, S. A. Motorny
Publikováno v:
Медицинский совет, Vol 0, Iss 17, Pp 111-120 (2021)
The article notes features of the last epidemic season (2020-2021) in the form of extremely low activity of influenza viruses with SARS-CoV-2 remaining dominant in the etiological structure of acute respiratory viral infections. Presented own data in
Externí odkaz:
https://doaj.org/article/decafc1092794dbf8f971fae63232838
Autor:
A. A. Sominina, D. M. Danilenko, K. A. Stolyarov, L. S. Karpova, M. I. Bakaev, T. P. Levanyuk, E. I. Burtseva, D. A. Lioznov
Publikováno v:
Эпидемиология и вакцинопрофилактика, Vol 20, Iss 4, Pp 28-39 (2021)
Background. Integrative epidemiological and etiological analysis of peculiarities of the development of the COVID-19 pandemic in different countries of the world is of significant scientific and practical interest in order to improve the preparedness
Externí odkaz:
https://doaj.org/article/c4cdb30f3b9146fb839b9eba204c64cc
Autor:
V. V. Lebedeva, I. T. Fedyakina, O. E. Latyshev, E. I. Burtseva, I. V. Kukes, D. V. Blinov, O. V. Eliseeva, V. F. Larichev, T. M. Garaev, T. V. Grebennikova
Publikováno v:
Эпидемиология и вакцинопрофилактика, Vol 20, Iss 3, Pp 83-90 (2021)
Due to the emergence of a new coronavirus infection COVID-19, scientists around the world are actively working on a vaccine against the SARS-CoV-2 coronavirus. At the same time, it is possible that existing medications can help in the fight against t
Externí odkaz:
https://doaj.org/article/679afaf6943443ffb82113649e2b390b
Autor:
D. K. L’vov, E. I. Burtseva, L. V. Kolobukhina, I. T. Fedyakina, N. V. Bovin, A. V. Ignatjeva, K. G. Krasnoslobodtsev, E. L. Feodoritova, S. V. Trushakova, N. V. Breslav, L. N. Merkulova, E. A. Mukasheva, I. N. Khlopova, O. L. Voronina, E. I. Aksyonova, M. S. Kunda, N. N. Ryzhova, R. V. Vartanjan, L. B. Kistenyova, I. M. Kirillov, E. S. Proshina, A. G. Rosatkevich, I. S. Kruzhkova, A. L. Zaplatnikov, M. V. Bazarova, S. V. Smetanina, M. V. Kharlamov, N. L. Karpov, A. V. Shikhin
Publikováno v:
Вопросы вирусологии, Vol 65, Iss 6, Pp 335-349 (2021)
Introduction. The surveillance of influenza viruses in ARVI structure and study of their properties in epidemic season 2019–2020 in Russian Federation are actual for investigations due to tasks of Global Influenza Strategy initiated by WHO in 2019.
Externí odkaz:
https://doaj.org/article/2110155f09a542c6b9457935a4b731e9
Autor:
A. N. Vasiliev, R. Z. Gatich, L. V. Kolobukhina, E. I. Isaeva, E. I. Burtseva, T. G. Orlova, F. V. Voronina, V. V. Malinovskaya
Publikováno v:
Антибиотики и Химиотерапия, Vol 54, Iss 3-4, Pp 21-25 (2020)
The therapeutic efficacy of Viferon® (suppositories of human recombinant interferon alfa-2) was investigated in a double-blind controlled study with the use of Arbidol® as a reference drug in the treatment of patients with influenza. Viferon® and
Externí odkaz:
https://doaj.org/article/1280cd07bc5b449f9c59552a7d6126e3
Autor:
E. G. Kondyurina, A. L. Zaplatnikov, T. N. Yelkina, E. I. Burtseva, O. A. Gribanova, N. I. Pirozhkova, G. A. Mingalimova, I. O. Tyuleneva, S. V. Trushakova, E. A. Mukasheva
Publikováno v:
Антибиотики и Химиотерапия, Vol 61, Iss 5-6, Pp 8-20 (2020)
A prospective, two-center, open-label, randomised clinical trial assessing the efficacy and tolerability of treatment strategies involving the administration of Ergoferon and Kagocel in paediatric outpatients aged over 3 years was carried out. The st
Externí odkaz:
https://doaj.org/article/8f20e78433024135bad7872db8529f39
Autor:
E. G. Kondyurina, I. O. Tyuleneva, E. I. Burtseva, S. V. Trushakova, E. A. Mukasheva, A. A. Vinogradova, T. N. Elkina, V. V. Zelenskaya
Publikováno v:
Антибиотики и Химиотерапия, Vol 61, Iss 9-10, Pp 33-43 (2020)
A randomized double-blind controlled study was carried out to evaluate changes in the clinical presentation of acute obstructive bronchitis in preschool children using antiviral, anti-inflammatory therapy. The study enrolled 54 subjects (aged 3-6 yea
Externí odkaz:
https://doaj.org/article/bb754ec946904ff8925a467567ee06ff
Publikováno v:
Вопросы вирусологии, Vol 65, Iss 1, Pp 6-15 (2020)
Results of analysis of phylogenetic, virological, epidemiological, ecological, clinical data of COVID-19 outbreaks in Wuhan, China (PRC) in comparison with SARS-2002 and MERS-2012 outbreaks allow to conclude: – the etiological agent of COVID-19 is
Externí odkaz:
https://doaj.org/article/6a7269df05644d56bcdf3fbb049e03e6